Business

ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 3rd, 2026 in Paris

LYON, France, May 11, 2026--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, announced today that it will hold its annual shareholders’ meeting ("AGM") on June 3rd, 2026, at 10:00 am, at the offices of Jones Day, Hotel de Talleyrand, 2 rue Saint Florentin, 75001 Paris.

articleAdocia SaMay 11, 20263/company/adocia-sa/news/adocia-announces-its-annual-shareholders-meeting-to-be-held-on-june-3rd-2026-in-paris
ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 3rd, 2026 in Paris

About this update from Adocia Sa

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3539,"height":1431,"url":"https://media.zenfs.com/en/business-wire.com/9a961c3b5d319d60249ebf4172170d24"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GHdT__GyDHo4HBR6E1fdOg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM4OA--/https://media.zenfs.com/en/business-wire.com/9a961c3b5d319d60249ebf4172170d24","width":960,"height":388},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/2DkCnmQ6GP2X6zLZFxU41w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTI1OQ--/https://media.zenfs.com/en/business-wire.com/9a961c3b5d319d60249ebf4172170d24","width":640,"height":259},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/WreN2YE0Bcw2lfDaWWeO8Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD05NzA-/https://media.zenfs.com/en/business-wire.com/9a961c3b5d319d60249ebf4172170d24","width":1200,"height":485}},"lazy":false},{"type":"text","content":"LYON, France, May 11, 2026--(BUSINESS WIRE)--Regulatory News:","length":61,"tagName":"p"},{"type":"text","content":"Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, announced today that it will hold its annual shareholders’ meeting ("AGM") on June 3rd, 2026, at 10:00 am, at the offices of Jones Day, Hotel de Talleyrand, 2 rue Saint Florentin, 75001 Paris.","length":410,"tagName":"p"},{"type":"text","content":"The notice of this shareholders’ meeting, which serves as the convening notice was published on April 27th, 2026 in the French Bulletin des Annonces Légales Obligatoires ("BALO"). It includes the agenda, the proposed resolutions and instructions for participating and voting at this meeting.","length":301,"tagName":"p"},{"type":"text","content":"In accordance with the regulations in force, all documentation concerning the meeting is available to shareholders on the Company's website: https://www.adocia.com/investors/general-meeting/","length":194,"tagName":"p"},{"type":"text","content":"The online voting platform will open on May 18, 2026, at 12:00 p.m. The Company will post a tutorial in the same section of its website to help shareholders become familiar with this online voting tool. Shareholders will have the o...

More updates from Adocia Sa

Euronext Parisshareholders’ meetingThe Companyonline votingbiopharmaceutical companyshareholdersHotel de Talleyrand